Clinical MS Research Group
Our single objective: to prevent and reverse disability for everyone with multiple sclerosis, neuromyelitis optica and MOG associated disease.
Research Themes
Cambridge Clinical Multiple Sclerosis Research Group is achieving this objective through six themes:
​
-
Personalising Treatments through Big Data and AI
-
Discovering and Proving New Repair therapies
-
Our Visual and MRI Outcome Development Program
-
Studying Children with MS, NMO and related conditions
-
Study ageing in multiple sclerosis
-
Measuring and sustainably addressing healthcare inequalities.
Currently our work is focused on:
-
Improving the availability of data in electonic health records in the UK for MS researchers
-
Using real-world data to answer important questions about how best to use MS therapies
-
Exploring how best to measure remyelination in adults and children with MS
-
Investigating natural remyelination in people with MS
-
Doing clinical trials to identify drugs which promote endogenous remyelination in people with MS
​​
Read more here.
Featured News
Remyelination Team Member Completes PhD!
16th May 2025
We are very proud to announce that Dr Gioia Riboni-Verri has successfully completed her PhD!
Read more here.
​
Cambridge Centre for Myelin Repair Symposium Update
7th May 2025
It was a pleasure to be heavily involved in the Cambridge Centre for Myelin Repair (CCMR) Symposium last week. The event is a fantastic way to network with neurologists and researchers in the fields of myelin biology and remyelination, as well as update people living with multiple sclerosis about all of the work we are conducting.
Continue reading here.
CCMSR Group Presents at MS Trust Conference
1st April 2025
It was fantastic to have the opportunity for members of our team to contribute to the recent MS Trust conference. Across the three day meeting, we had Dr Will Brown discuss the importance of big data and Courtney Kremler present on the use of artificial intelligence (AI) in the MS clinic
Read more here.​​
​